Sai Life Sciences Limited has submitted a declaration to the National Stock Exchange and BSE confirming that its promoters and promoter group did not create any fresh encumbrance on their shares during the financial year ended March 31, 2026. The filing states that no shares were pledged or otherwise encumbered beyond those already disclosed during the year.
Krishnam Raju Kanumuri, a promoter of Sai Life Sciences, filed the disclosure under Regulation 31(4) of the SEBI Takeover Regulations. The declaration covers all members of the promoter and promoter group, including persons acting in concert.
Sai Life Sciences provided a detailed annexure listing 46 entities across the promoter and promoter group categories. Among the promoters are Ranga Raju Kanumuri, Mytreyi Kanumuri, and Krishnam Raju Kanumuri, along with partnership firms Lily Partners, Tulip Partners, Marigold Partners, and Sunflower Partners.
Sai Quest Syn Private Limited is listed as a promoter entity. The promoter group includes individuals Sudha Kanumuri, Gokaraju Subba Raju, Tanuja Gokaraju, Bapi Raju Kanumuri, and others. Entity-level promoter group members include Continental Wines P Ltd, Chemrich Fine Chemicals Private Limited, South India Research Institute Private Limited, and multiple family trusts and partnership firms.
Other promoter group entities listed in the disclosure include Chrysanthemum Family Trust, Lily Family Trust, Marigold Family Trust, Orchid Family Trust, Sunflower Family Trust, and Tulip Family Trust. The disclosure also lists JRV Properties LLP, Ranmyt Trading Private Limited, Siri Pharma, Siris Herbex, Siris Impex, and Hutansa as part of the promoter group.
Disclaimer: This article is based on company filings submitted to the Bombay Stock Exchange (BSE) and National Stock Exchange of India (NSE) and is for informational purposes only. It does not constitute investment advice or a recommendation. Investors should conduct their own research and consult a qualified financial advisor before making investment decisions.